Contribute to Manishpatel012/Mrp development by creating an account on GitHub.

Functional constipation, also known as chronic idiopathic constipation, is diagnosed when a person is experiencing constipation symptoms, but no specific cause for the problem can be identified.

Motegrity is a medication used to treat chronic idiopathic constipation (CIC) in adults. The FDA has granted Competitive Generic Therapy (CGT) designation to the company's Prucalopride ...

Constipation is a frequently reported bowel ... Hirschprung's disease, multiple sclerosis. Idiopathic Paraneoplastic syndromes, Parkinson's disease, dementia, scleroderma, post-viral colon-paresis ...

The first generic version of Motegrity has been approved by the Food and Drug Administration and is now available.

ANI is offering prucalopride tablets, which is the generic of Takeda's Motegrity. Motegrity is used in adults to treat chronic idiopathic constipation. "We are delighted to build momentum early in ...

Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation, regardless of age, BMI or renal function, ...

Chronic constipation is the prototype of functional ... multiple sclerosis. Idiopathic Paraneoplastic syndromes, Parkinson's disease, dementia, scleroderma, post-viral colon-paresis, intestinal ...